RxDoctor Payments Data

Yolanda Bryce, MD

Diagnostic Radiology · New York, NYNPI 1093941791

Payments from drug & device makers

$73,349in general payments, 2019–2025

Across 88 payments — averaging $833.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$57K
  • Shockwave Medical, Inc$6K
  • Whitehall International Inc$3K
  • Penumbra, Inc.$3K
  • Bioptics, Inc.$2K
  • Hologic Inc$1K
  • plus $791 from 4 others

What the payments were for

  • Consulting fees$14,46531%
  • Speaking & faculty fees$27,05059%
  • Grants$7502%
  • Travel & lodging$7322%
  • Food & beverage$3,0457%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific66$57,387
Shockwave Medical, Inc3$5,500
Whitehall International Inc1$3,465
Penumbra, Inc.3$2,557
Bioptics, Inc.1$2,400
Hologic Inc4$1,249
Inari Medical, Inc.7$572
Siemens Medical Solutions USA, Inc.1$140
Cook Medical LLC1$63
Abbott1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,349 in reported general payments places this provider in the 95th percentile of 2,530 diagnostic radiology providers in New York.

See all diagnostic radiology providers in New York

Medicare billing

Part B allowed, 2024
$89,389
Medicare patients
626
Services billed
1,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban35$25,496
EliquisApixaban39$22,175

Paid to pharmacies, not to this prescriber.

Other diagnostic radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →